{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-068018","form_type":"8-K/A","ticker":"PHGE","cik":"0001739174","company_name":"BiomX Inc.","filed_at":"2026-06-12T12:53:52+00:00","discovered_at":"2026-06-12T12:55:00.297171+00:00","generated_at":"2026-06-12T12:55:19.825965+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"BiomX filing reveals Zorronet FY2025: $0 cash, $643K deficit, going concern flagged","bullets":["Zorronet had $0 cash, $554K negative working capital, and $643K stockholders' deficit as of Dec 31, 2025.","Net loss of $306K on $617K revenue; gross profit $168K; operating loss $283K.","Auditor KPMG includes going concern emphasis; parent support uncertain.","Israel-hostilities note describes ceasefire Sept 2025 but renewed escalation Feb 2026; impact unquantified.","DFSL audited/unaudited financials also filed; pro forma statements give combined view of both acquisitions."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-068018","json":"https://secwatch.observer/filing/0001213900-26-068018.json","markdown":"https://secwatch.observer/filing/0001213900-26-068018.md","text":"https://secwatch.observer/filing/0001213900-26-068018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026068018/0001213900-26-068018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739174/000121390026068018/ea0293407-8ka1_biomx.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T12:55:19.825965+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}